Mr. Erwin is president of iBio, Inc. (AMEX: IBIO), a biotechnology company commercializing a green plant platform for vaccines and therapeutic proteins, and he is chairman of Novici Biotech LLC (Vacaville, California). From 2003 until 2007 he was managing director of Bio-Strategic Directors LLC, a life science-industry consulting firm focused on intellectual property and strategy. He was chief executive officer of Large Scale Biology Corporation from 1992 to 2003 and served as its chairman until 2006. He was chairman of Icon Genetics AG from 1999 until its acquisition by a subsidiary of Bayer AG in 2006. Mr. Erwin is also active in the not-for-profit sector and has served as president of the Marti Nelson Cancer Foundation since 1994. He is a member of the National Cancer Policy Forum of the Institute of Medicine, a former member of the Data and Safety Monitoring Board for the Cancer and Leukemia Group B, and the Research Committee of the American Society of Clinical Oncology. He served as a member of the California Breast Cancer Research Council from 1996 to 1999 and was its chairman from 1997 to 1999. Mr. Erwin is an inventor on several issued and pending patents and has B.S. and M.S. degrees in zoology and genetics from Louisiana State University.